R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Read More…
Industry, Sector and Symbol
Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
Phone312-324-7820
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$868.50 million
Profitability
Miscellaneous
Employees18,600
Next Earnings Date11/5/2019 (Confirmed)
OptionableNot Optionable
R1 RCM (NASDAQ:RCM) Frequently Asked Questions
What is R1 RCM's stock symbol?
R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
How were R1 RCM's earnings last quarter?
R1 RCM Inc (NASDAQ:RCM) issued its earnings results on Tuesday, August, 6th. The healthcare provider reported ($0.09) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.08. The healthcare provider had revenue of $295 million for the quarter, compared to analyst estimates of $294.11 million. R1 RCM had a negative return on equity of 249.01% and a negative net margin of 2.22%. The firm's revenue for the quarter was up 41.9% on a year-over-year basis. During the same period last year, the company posted ($0.07) earnings per share. View R1 RCM's Earnings History.
When is R1 RCM's next earnings date?
How can I listen to R1 RCM's earnings call?
R1 RCM will be holding an earnings conference call on Tuesday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has R1 RCM issued on next quarter's earnings?
R1 RCM updated its FY 2019 earnings guidance on Tuesday, September, 24th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.175-1.2 billion, compared to the consensus revenue estimate of $1.23 billion.
What price target have analysts set for RCM?
4 brokerages have issued 1 year price targets for R1 RCM's stock. Their forecasts range from $10.00 to $20.00. On average, they anticipate R1 RCM's share price to reach $14.25 in the next year. This suggests a possible upside of 39.2% from the stock's current price. View Analyst Price Targets for R1 RCM.
What is the consensus analysts' recommendation for R1 RCM?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.
Has R1 RCM been receiving favorable news coverage?
Media coverage about RCM stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. R1 RCM earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave news stories about the healthcare provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for R1 RCM.
Are investors shorting R1 RCM?
R1 RCM saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 6,960,000 shares, an increase of 9.4% from the August 30th total of 6,360,000 shares. Based on an average trading volume of 961,400 shares, the short-interest ratio is presently 7.2 days. Currently, 7.2% of the shares of the stock are short sold. View R1 RCM's Current Options Chain.
Who are some of R1 RCM's key competitors?
Some companies that are related to R1 RCM include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), BioScrip (BIOS), Cross Country Healthcare (CCRN), Interpace Diagnostics Group (IDXG) and Bio-Reference Laboratories (BRLI).
What other stocks do shareholders of R1 RCM own?
Who are R1 RCM's key executives?
R1 RCM's management team includes the folowing people:
- Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
- Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
- Mr. Richard B. Evans Jr., Sr. VP, Interim CFO, Corp. Controller & Chief Accounting Officer (Age 51)
- Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
- Mr. Corey Perman, Exec. VP of Compliance & Risk
Who are R1 RCM's major shareholders?
R1 RCM's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Hennessy Advisors Inc. (0.25%), Calamos Advisors LLC (0.23%), Strs Ohio (0.07%) and Zurcher Kantonalbank Zurich Cantonalbank (0.01%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.
Which institutional investors are selling R1 RCM stock?
Which institutional investors are buying R1 RCM stock?
RCM stock was acquired by a variety of institutional investors in the last quarter, including Strs Ohio, Calamos Advisors LLC and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for R1 RCM.
How do I buy shares of R1 RCM?
Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is R1 RCM's stock price today?
One share of RCM stock can currently be purchased for approximately $10.24.
How big of a company is R1 RCM?
R1 RCM has a market capitalization of $1.15 billion and generates $868.50 million in revenue each year. The healthcare provider earns $-45,300,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. R1 RCM employs 18,600 workers across the globe.View Additional Information About R1 RCM.
What is R1 RCM's official website?
How can I contact R1 RCM?
R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The healthcare provider can be reached via phone at 312-324-7820 or via email at [email protected]
MarketBeat Community Rating for R1 RCM (NASDAQ RCM)
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
